Triple_Barrel_Capital

$VRTX Reversing Off Upper Channel Limit

Short
NASDAQ:VRTX   Vertex Pharmaceuticals Incorporated
$VRTX Vertex looking over-extended, reversing off the long term upper channel limit. Barring an earnings home run next week, expecting further price correction in the coming weeks and months.

Medium term target: $163.50
Long term target: $153.50 (lower channel support)



Earnings next week, 7/25










Note: Observation/opinion, not investment advice.

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.